{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:58:07Z","timestamp":1770191887918,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI119762"],"award-info":[{"award-number":["R01AI119762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI121349"],"award-info":[{"award-number":["R01AI121349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BBB-BQB\/3494\/2014"],"award-info":[{"award-number":["PTDC\/BBB-BQB\/3494\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bbamem.2021.183762","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:59:18Z","timestamp":1630447158000},"page":"183762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The pH-sensitive action of cholesterol-conjugated peptide inhibitors of influenza virus"],"prefix":"10.1016","volume":"1863","author":[{"given":"Patr\u00edcia M.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo T.","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Porotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2021.183762_bb0005","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/JVI.02326-15","article-title":"Identification of novel fusion inhibitors of influenza A virus by chemical genetics","volume":"90","author":"Lai","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0010","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1021\/acs.jpcb.6b06775","article-title":"Lowered pH leads to fusion peptide release and a highly dynamic intermediate of influenza hemagglutinin","volume":"120","author":"Lin","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbamem.2021.183762_bb0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2021.183762_bb0020","doi-asserted-by":"crossref","unstructured":"O. Nyanguile, Peptide antiviral strategies as an alternative to treat lower respiratory viral infections, Front. Immunol. (2019) 1366, https:\/\/doi.org\/10.3389\/fimmu.2019.01366.","DOI":"10.3389\/fimmu.2019.01366"},{"key":"10.1016\/j.bbamem.2021.183762_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejphar.2017.05.038","article-title":"New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections","volume":"809","author":"van de Wakker","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/v11020122","article-title":"Back to the future for influenza preimmunity\u2014looking back at influenza virus history to infer the outcome of future infections","volume":"11","author":"Francis","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.bbamem.2021.183762_bb0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2021.183762_bb0040","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s00018-014-1615-2","article-title":"Antiviral strategies against influenza virus: towards new therapeutic approaches","volume":"71","author":"Loregian","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamem.2021.183762_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbamem.2021.183762_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/med.21289","article-title":"Emerging antiviral strategies to interfere with influenza virus entry","volume":"34","author":"Vanderlinden","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbamem.2021.183762_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1542\/pir.35.6.217","article-title":"Influenza and parainfluenza viral infections in children","volume":"35","author":"Fox","year":"2014","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.bbamem.2021.183762_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0065","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza A virus cell entry, replication, virion assembly and movement","volume":"9","author":"Dou","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0070","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.micinf.2004.05.002","article-title":"Endocytosis of influenza viruses","volume":"6","author":"Lakadamyali","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bbamem.2021.183762_bb0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coviro.2011.06.002","article-title":"Cell entry of enveloped viruses","volume":"1","author":"Plemper","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0085","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"Russell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2021.183762_bb0090","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1128\/JVI.00135-10","article-title":"Viral entry inhibitors targeted to the membrane site of action","volume":"84","author":"Porotto","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures and mechanisms of viral membrane fusion proteins","volume":"43","author":"White","year":"2008","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001168","article-title":"Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry","volume":"6","author":"Porotto","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbamem.2021.183762_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009830","article-title":"HIV-1 fusion inhibitor peptides enfuvirtide and T-1249 interact with erythrocyte and lymphocyte membranes","volume":"5","author":"Matos","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2021.183762_bb0110","doi-asserted-by":"crossref","first-page":"42141","DOI":"10.1074\/jbc.M111.254243","article-title":"Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2021.183762_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060302","article-title":"Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action","volume":"8","author":"Hollmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2021.183762_bb0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/jac\/dkt529","article-title":"Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure infection","volume":"69","author":"Augusto","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbamem.2021.183762_bb0125","doi-asserted-by":"crossref","first-page":"43610","DOI":"10.1038\/srep43610","article-title":"Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides","volume":"7","author":"Mathieu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamem.2021.183762_bb0130","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/molecules22071190","article-title":"Antiviral lipopeptide-cell membrane interaction is influenced by PEG linker length","volume":"22","author":"Augusto","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bbamem.2021.183762_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/psc.1005","article-title":"Interaction of peptides with biomembranes assessed by potential-sensitive fluorescent probes","volume":"14","author":"Matos","year":"2008","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.bbamem.2021.183762_bb0140","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.nano.2015.02.014","article-title":"Effects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitecture","volume":"11","author":"Hollmann","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbamem.2021.183762_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.colsurfb.2017.01.032","article-title":"Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies","volume":"152","author":"Augusto","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbamem.2021.183762_bb0150","article-title":"In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence","volume":"91","author":"Figueira","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamem.2021.183762_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036833","article-title":"A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity","volume":"7","author":"Pessi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2021.183762_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2736(86)90302-0","article-title":"Vesicles of variable sizes produced by a rapid extrusion procedure","volume":"858","author":"Mayer","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2021.183762_bb0165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0005-2736(80)90558-1","article-title":"Preparation of unilamellar liposomes of intermediate size (0.1\u20130.2\u202f\u03bcm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes","volume":"601","author":"Szoka","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2021.183762_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0005-2736(03)00112-3","article-title":"Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods","volume":"1612","author":"Santos","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2021.183762_bb0175","doi-asserted-by":"crossref","unstructured":"P.M. Matos, H.G. Franquelim, M.A.R.B. Castanho, N.C. Santos, Quantitative assessment of peptide-lipid interactions. Ubiquitous fluorescence methodologies, Biochim. Biophys. Acta 1798 (2010) 1999\u20132012. doi:https:\/\/doi.org\/10.1016\/j.bbamem.2010.07.012.","DOI":"10.1016\/j.bbamem.2010.07.012"},{"key":"10.1016\/j.bbamem.2021.183762_bb0180","doi-asserted-by":"crossref","unstructured":"S.T. Henriques, L.K. Pattenden, M.-I. Aguilar, M. a R.B. Castanho, PrP(106\u2013126) does not interact with membranes under physiological conditions., Biophys. J. 95 (2008) 1877\u20131889. doi:https:\/\/doi.org\/10.1529\/biophysj.108.131458.","DOI":"10.1529\/biophysj.108.131458"},{"key":"10.1016\/j.bbamem.2021.183762_bb0185","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1021\/ja711247n","article-title":"Sifuvirtide screens rigid membrane surfaces. Establishment of a correlation between efficacy and membrane domain selectivity among HIV fusion inhibitor peptides","volume":"130","author":"Franquelim","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2021.183762_bb0190","doi-asserted-by":"crossref","unstructured":"M. Yamazaki, M. Miyazu, T. Asano, a Yuba, N. Kume, Direct evidence of induction of interdigitated gel structure in large unilamellar vesicles of dipalmitoylphosphatidylcholine by ethanol: studies by excimer method and high-resolution electron cryomicroscopy., Biophys. J. 66 (1994) 729\u2013733. doi:https:\/\/doi.org\/10.1016\/S0006-3495(94)80848-3.","DOI":"10.1016\/S0006-3495(94)80848-3"},{"key":"10.1016\/j.bbamem.2021.183762_bb0195","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1021\/bi9803933","article-title":"Interaction of the major epitope region of HIV protein gp41 with membrane model systems. A fluorescence spectroscopy study","volume":"37","author":"Santos","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2021.183762_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-2697(02)00024-6","article-title":"Joint determination by Brownian dynamics and fluorescence quenching of the in-depth location profile of biomolecules in membranes","volume":"307","author":"Fernandes","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbamem.2021.183762_bb0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbrc.2010.11.013","article-title":"The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide","volume":"403","author":"Matos","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2021.183762_bb0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0006-3495(94)80471-0","article-title":"Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential","volume":"67","author":"Gross","year":"1994","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2021.183762_bb0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0005-2736(96)00188-5","article-title":"Optical detection of membrane dipole potential: avoidance of fluidity and dye-induced effects","volume":"1323","author":"Clarke","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2021.183762_bb0220","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/S0006-3495(98)77951-2","article-title":"Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide","volume":"74","author":"Cladera","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2021.183762_bb0225","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bbamem.2014.02.019","article-title":"Measuring membrane penetration with depth-dependent fluorescence quenching: distribution analysis is coming of age","volume":"1838","author":"Ladokhin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2021.183762_bb0230","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1111\/trf.12080","article-title":"Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality","volume":"53","author":"Almizraq","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.bbamem.2021.183762_bb0235","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbalip.2008.07.008","article-title":"Mass spectrometric analysis of lipid species of human circulating blood cells","volume":"1781","author":"Leidl","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2021.183762_bb0240","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1021\/acs.bioconjchem.8b00527","article-title":"Effective in vivo targeting of influenza virus through a cell-penetrating\/fusion inhibitor tandem peptide anchored to the plasma membrane","volume":"29","author":"Figueira","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbamem.2021.183762_bb0245","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/acsinfecdis.8b00321","article-title":"Combining 25-hydroxycholesterol with an HIV fusion inhibitor peptide: interaction with biomembrane model systems and human blood cells","volume":"5","author":"Gomes","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bbamem.2021.183762_bb0250","doi-asserted-by":"crossref","unstructured":"R.D. de Vries, K.S. Schmitz, F.T. Bovier, C. Predella, J. Khao, D. Noack, B.L. Haagmans, S. Herfst, K.N. Stearns, J. Drew-Bear, S. Biswas, B. Rockx, G. McGill, N.V. Dorrello, S.H. Gellman, C.A. Alabi, R.L. de Swart, A. Moscona, M. Porotto, Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets, Science 371 (2021) 1379\u20131382, https:\/\/doi.org\/10.1126\/science.abf4896.","DOI":"10.1126\/science.abf4896"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273621002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273621002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:52:46Z","timestamp":1762091566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273621002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0005273621002108"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2021.183762","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pH-sensitive action of cholesterol-conjugated peptide inhibitors of influenza virus","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Biomembranes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamem.2021.183762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"183762"}}